|
ATXN7L3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.30870000000172E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.038500E-03 |
| Normal-vs-Stage2 |
9.869600E-02 |
| Normal-vs-Stage3 |
1.342250E-02 |
| Normal-vs-Stage4 |
5.869600E-01 |
| Stage1-vs-Stage2 |
8.302000E-01 |
| Stage1-vs-Stage3 |
7.306800E-01 |
| Stage1-vs-Stage4 |
3.934600E-01 |
| Stage2-vs-Stage3 |
6.521800E-01 |
| Stage2-vs-Stage4 |
5.321800E-01 |
| Stage3-vs-Stage4 |
3.055600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.019730E-04 |
| Normal-vs-AfricanAmerican |
5.600100E-02 |
| Normal-vs-Asian |
1.753040E-01 |
| Caucasian-vs-AfricanAmerican |
1.374760E-01 |
| Caucasian-vs-Asian |
4.762600E-01 |
| AfricanAmerican-vs-Asian |
1.667370E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.377500E-04 |
| Normal-vs-Female |
4.037800E-04 |
| Male-vs-Female |
4.450400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.079970E-01 |
| Normal-vs-Extreme_Weight |
2.184000E-03 |
| Normal-vs-Obese |
3.381200E-03 |
| Normal-vs-Extreme_Obese |
1.438350E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.588000E-01 |
| Normal_Weight-vs-Obese |
3.159400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.123000E-01 |
| Extreme_Weight-vs-Obese |
8.579800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.728600E-01 |
| Obese-vs-Extreme_Obese |
9.494000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.3667000000025E-05 |
| Normal-vs-Age(41-60Yrs) |
1.8773000000083E-06 |
| Normal-vs-Age(61-80Yrs) |
2.205500E-02 |
| Normal-vs-Age(81-100Yrs) |
5.449800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.287600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.997600E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.986100E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.316600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.718100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.958000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62239999990099E-07 |
| Normal-VS-Type2 PRCC |
4.507600E-01 |
| Normal-VS-KIRP CIMP |
4.34429999995878E-06 |
| Normal-VS-Unclassified PRCC |
3.242700E-03 |
| Type1 PRCC-VS-Type2 PRCC |
1.5875999959114E-08 |
| Type1 PRCC-VS-KIRP CIMP |
3.170800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.574800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.002590E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
4.839000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
8.231600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.428100E-02 |
| Normal-vs-N1 |
5.561600E-02 |
| Normal-vs-N2 |
2.302100E-03 |
| N0-vs-N1 |
4.308800E-01 |
| N0-vs-N2 |
1.297220E-01 |
| N1-vs-N2 |
3.453400E-01 |
|
|
